Idelalisib - søkeresultat

Den europeiske union - tysk - EMA (European Medicines Agency)

libtayo

regeneron ireland designated activity company (dac) - cemiplimab - karzinom, plattenepithelkarzinom - antineoplastische mittel - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

irinotecan sun 1,5 mg/ml infusionslösung

sun pharmaceuticals germany gmbh (8127792) - irinotecanhydrochlorid 3 h<2>o - infusionslösung - 1,5 mg/ml - teil 1 - infusionslösung; irinotecanhydrochlorid 3 h<2>o (28859) 1,5 milligramm

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

irinotecan kelix bio 20 mg/ml konzentrat zur herstellung einer infusionslösung

kelix bio (malta) ltd. (1010499) - irinotecanhydrochlorid 3 h<2>o - konzentrat zur herstellung einer infusionslösung - 20 mg/ml irinotecanhydrochlorid 3 h<2>o - teil 1 - konzentrat zur herstellung einer infusionslösung; irinotecanhydrochlorid 3 h<2>o (28859) 20 milligramm

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

irinotecan phares 20 mg/ml konzentrat zur herstellung einer infusionslösung

pharma resources gmbh (8139312) - irinotecanhydrochlorid 3 h<2>o - konzentrat zur herstellung einer infusionslösung - 20 mg/ml irinotecanhydrochlorid 3 h<2>o - teil 1 - konzentrat zur herstellung einer infusionslösung; irinotecanhydrochlorid 3 h<2>o (28859) 20 milligramm

Tyskland - tysk - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

irinotecan amarox 20 mg/ml konzentrat zur herstellung einer infusionslösung

amarox pharma gmbh (8110952) - konzentrat zur herstellung einer infusionslösung - 20 mg/ml